New Sickle Cell Disease Clinical Trial in the UK

New Sickle Cell Disease Clinical Trial in the UK

New Sickle Cell Disease Clinical Trials in the UK

Despite years of research and development, treatment options for patients with sickle cell disease remain limited. More recently, companies and researchers have started to develop new therapies to help improve patient lives. Clinical studies help researchers better understand a disease and how best to treat it, with the ultimate goal to develop new treatments for patients. Join the Sickle Cell Society and Imara Inc for a Sunday lunch to learn about new clinical studies for adult patients living with sickle cell disease being conducted in the UK. Book your free place here.

Imara Inc., is a U.S.-based company focused on advancing novel treatments for sickle cell disease and other hemoglobinopathies.

Book your free place here:

Order Speaker Time
Guests Arrive and Register 1200 – 1230
LUNCH 1230 – 1330
Welcome John James – CEO Sickle Cell Society 13:35 – 1345
Importance of Research & Development, current clinical trials

and the unmet medical need in Sickle Cell Disease.


Dr Perla Eleftheriou – UCLH

1345 – 1415
COFFEE BREAK / 1415 – 1430
Scientific Data IMR 687 Dr James McArthur – Imara 1430 – 1510
Phase 1 Data IMR 687 Dr Shi Yin Foo – Cydan II 1510 – 1535
Phase 2a study Dr Arne Dekreuk – Croydon University Hospital 1535 – 1550
Questions and Answer Session 1550 -1610
CLOSE 1620

Leave a Reply